US Stock MarketDetailed Quotes

MRNA Moderna

Watchlist
  • 106.980
  • +2.520+2.41%
Trading Apr 23 10:48 ET
40.96BMarket Cap-8676P/E (TTM)

About Moderna Company

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Company Profile

SymbolMRNA
Company NameModerna
Listing DateDec 7, 2018
Issue Price23.00
Founded2010
CEOMr. Stephane Bancel
MarketNASDAQ
Employees5600
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address200 Technology Square
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-714-6500

Company Executives

  • Name
  • Position
  • Salary
  • Stephane Bancel
  • Director and Chief Executive Officer
  • 17.07M
  • James M Mock
  • Chief Financial Officer and Principal Accounting Officer
  • 4.32M
  • Tracey Franklin
  • Chief Human Resources Officer
  • --
  • Shannon Thyme Klinger
  • Chief Legal Officer and Corporate Secretary
  • 4.31M
  • Jerh Collins
  • Chief Technical Operations and Quality Officer
  • --
  • Kate Cronin
  • Chief Brand Officer
  • --
  • Brad Miller
  • Chief Information Officer
  • --
  • Dr. Stephen Hoge, M.D.
  • President
  • 7.34M
  • Dr. Noubar B. Afeyan, PhD
  • Chairman of the Board
  • 663.52K
  • Stephen Berenson
  • Independent Director
  • 471.25K
  • Dr. Sandra J. Horning, M.D.
  • Independent Director
  • 481.27K
  • Elizabeth E. Tallett
  • Independent Director
  • 481.27K
  • Paul Sagan
  • Independent Director
  • 461.27K
  • Dr. Francois Nader, M.D.
  • Independent Director
  • 481.27K
  • Dr. Elizabeth G. Nabel, M.D.
  • Independent Director
  • 476.25K
  • Dr. Robert S. Langer, Sc.D.
  • Independent Director
  • 461.27K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg